Greenwich LifeSciences GLSI
NASDAQ GLSI
$17.35 -0.70 (-3.88%)
At close: Oct 1, 2026 · 4:00 PM EDT

Greenwich LifeSciences (GLSI) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Greenwich LifeSciences' Liabilities and Shareholders Equity was $10.51 million in Q1 2026, up 281.9% from $2.75 million a year earlier and up 70.0% from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Greenwich LifeSciences came in at $6.18 million, up 50.9% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -26.4% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $4.09 million in FY2024 (-41.5%), $6.99 million in FY2023 (-48.1%), $13.48 million in FY2022 (-50.5%) and $27.22 million in FY2021 (-5.1%).
  • The Q1 2026 figure marks the highest quarterly Liabilities and Shareholders Equity since Q2 2023.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in two of the last eight quarters, with growth averaging 9.9%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 360.9%); the worst was Q2 2025 (a decline of 56.8%).
  • Per Business Quant data, GLSI's Liabilities and Shareholders Equity in the three quarters before Q1 2026 was $6.18 million (Q4 2025), $3.81 million (Q3 2025) and $3.13 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Greenwich LifeSciences 264.72 Mn 264.72 Mn - 10.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10.51 Mn
Dec 31, 2025 6.18 Mn
Sep 30, 2025 3.81 Mn
Jun 30, 2025 3.13 Mn
Mar 31, 2025 2.75 Mn
Dec 31, 2024 4.09 Mn
Sep 30, 2024 5.83 Mn
Jun 30, 2024 7.23 Mn
Mar 31, 2024 5.51 Mn
Dec 31, 2023 6.99 Mn
Sep 30, 2023 9.15 Mn
Jun 30, 2023 10.95 Mn
Mar 31, 2023 11.92 Mn
Dec 31, 2022 13.48 Mn
Sep 30, 2022 15.65 Mn
Jun 30, 2022 17.20 Mn
Mar 31, 2022 19.75 Mn
Dec 31, 2021 27.22 Mn
Sep 30, 2021 28.92 Mn
Jun 30, 2021 29.82 Mn
API Access

Greenwich LifeSciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GLSI&period=max&api_key=YOUR_API_KEY